Lysine-Rich Histone (H1) Is a Lysyl Substrate of Tissue Transglutaminase: Possible Involvement of Transglutaminase in the Formation of Nuclear Aggregates in (CAG)n/Qn Expansion Diseases

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Developmental Neuroscience

• Publication date

  2000-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000017470PMID 11111157
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aging process is accompanied by increase of transglutaminase C.

  1999cited by this paper
• Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei.

  1999influential reference
• Pathogenesis of Inclusion Bodies in (CAG)n/Qn‐Expansion Diseases with Special Reference to the Role of Tissue Transglutaminase and to Selective Vulnerability

  1999cited by this paper
• Huntingtin aggregates may not predict neuronal death in Huntington's disease

  1999cited by this paper
• Differential Expression of Multiple Transglutaminases in Human Brain

  1999influential reference
• Huntington aggregates may not predict neuronal death in Huntington's disease.

  1999cited by this paper
• Identification of ‘tissue’ transglutaminase binding proteins in neural cells committed to apoptosis

  1999cited by this paper
• The length of polyglutamine tract, its level of expression, the rate of degradation, and the transglutaminase activity influence the formation of intracellular aggregates.

  1999cited by this paper
• Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1

  1998cited by this paper
• `Tissue' transglutaminase in cell death: a downstream or a multifunctional upstream effector?

  1998cited by this paper
• Modulation of the in Situ Activity of Tissue Transglutaminase by Calcium and GTP*

  1998cited by this paper
• Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch

  1998cited by this paper
• Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases.

  1998cited by this paper
• Alteration of nucleosome structure as a mechanism of transcriptional regulation.

  1998cited by this paper
• Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?

  1998cited by this paper
• Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

  1998cited by this paper
• Isolation and characterization of brain-specific transglutaminases from rat

  1998cited by this paper
• Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia.

  1998cited by this paper
• A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

  1998cited by this paper
• Histone acetylation and X inactivation.

  1998cited by this paper
• Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine.

  1998cited by this paper
• Identification of amine acceptor protein substrates of transglutaminase in liver extracts: use of 5-(biotinamido) pentylamine as a probe.

  1998cited by this paper
• Distinct Nuclear Localization and Activity of Tissue Transglutaminase*

  1998cited by this paper
• Roles of histone acetyltransferases and deacetylases in gene regulation

  1998cited by this paper
• Expanded trinucleotide CAG repeats in families with bipolar affective disorder.

  1997cited by this paper
• Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length.

  1997cited by this paper
• Subcellular Distribution of Glyceraldehyde‐3‐Phosphate Dehydrogenase in Cerebellar Granule Cells Undergoing Cytosine Arabinoside‐Induced Apoptosis

  1997cited by this paper
• Polyglutamine Domains Are Substrates of Tissue Transglutaminase: Does Transglutaminase Play a Role in Expanded CAG/Poly‐Q Neurodegenerative Diseases?

  1997cited by this paper
• Identification of tissue transglutaminase as the autoantigen of celiac disease

  1997cited by this paper
• Structure of a covalently cross-linked form of core histones present in the starfish sperm.

  1997cited by this paper
• A fluorescent substrate of transglutaminase for detection and characterization of glutamine acceptor compounds.

  1997cited by this paper
• Use of the transglutaminase reaction to study the dissociation of histone N-terminal tails from DNA in nucleosome core particles.

  1997influential reference
• Polyglutamines, nuclear inclusions and neurodegeneration

  1997cited by this paper
• Transglutaminase activity is increased in Alzheimer's disease brain.

  1997cited by this paper
• The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP.

  1997cited by this paper
• Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH

  1996cited by this paper
• Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system.

  1996cited by this paper
• Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase.

  1996cited by this paper
• Core Histones Are Glutaminyl Substrates for Tissue Transglutaminase*

  1996cited by this paper
• Neurodegenerative diseases and transglutaminase.

  1996cited by this paper
• Neurokinin Receptors Could Be Differentiated by Their Capacity to Respond to the Transglutaminase‐Synthesized γ‐(Glutamyl5)Spermine Derivative of Substance P

  1995cited by this paper
• Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis.

  1995cited by this paper
• Substrate Requirements for Transglutaminases

  1995cited by this paper
• Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nuclei.

  1995cited by this paper
• Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum.

  1995cited by this paper
• Transglutaminases: Protein Cross-Linking Enzymes in Tissues and Body Fluids

  1994influential reference
• A rapid and simple method for the purification of transglutaminase from Streptoverticillium mobaraense.

  1994cited by this paper
• Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism.

  1993cited by this paper
• Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion

  1992cited by this paper
• Practical Handbook of Biochemistry and Molecular Biology

  1989cited by this paper
• Substance P as a transglutaminase substrate: identification of the reaction products by fast atom bombardment mass spectrometry.

  1988cited by this paper
• B-lipotropin 61-76 and 61-91 fragments act as transglutaminase substrates in vitro.

  1988cited by this paper
• Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels

  1987cited by this paper
• Fibrin-stabilizing factor (factor XIII).

  1976cited by this paper
• COMPARATIVE STUDIES ON TISSUE TRANSGLUTAMINASE AND FACTOR XIII

  1972cited by this paper
• The molecular weights of vertebrate histones exploiting a modified sodium dodecyl sulfate electrophoretic method.

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Transglutaminase: mechanistic features of the active site as determined by kinetic and inhibitor studies.

  1966cited by this paper

• Emerging histone glutamine modifications mediated gene expression in cell differentiation and the VTA reward pathway.

  2020cites this paper
• Histone Glutamine Modification by Neurotransmitters: Paradigm Shift in the Epigenetics of Neuronal Gene Activation and Dopaminergic VTA Reward Pathway

  2020cites this paper
• The dynamic nature of transglutaminases

  2018cites this paper
• Detection and identification of potential transglutaminase 2 substrates in the mouse renal glomeruli.

  2018cites this paper
• Tissue transglutaminase (TG2) and mitochondrial function and dysfunction.

  2017cites this paper
• Role of tissue transglutaminase-2 (TG2)-mediated aminylation in biological processes

  2017cites this paper
• Uncovering protein polyamination by the spermine-specific antiserum and mass spectrometric analysis

  2015cites this paper
• TGM2 and implications for human disease: role of alternative splicing.

  2013cites this paper
• Déjà vu with a twist: transglutaminases in bioenergetics and transcriptional dysfunction in Huntington's disease

  2010cites this paper
• Transglutaminase in the life and death of the pancreatic β-cell

  2010cites this paper
• Transglutaminase activation in neurodegenerative diseases.

  2009cites this paper
• Transglutaminases and neurodegeneration

  2009cites this paper
• Transglutaminase-like activity participates in cell wall biogenesis in Saccharomyces cerevisiae

  2007cites this paper
• The role of transglutaminase-2 and its substrates in human diseases.

  2006cites this paper
• Mammalian transglutaminases

  2005cites this paper
• Transglutaminase and diseases of the central nervous system.

  2005cites this paper
• Perfluorocarbon Emulsion Improves Cerebral Oxygenation and Mitochondrial Function after Fluid Percussion Brain Injury in Rats

  2004cites this paper
• Factor XIII subunit A as an intracellular transglutaminase

  2003cites this paper
• Oligomeric and polymeric aggregates formed by proteins containing expanded polyglutamine

  2003cites this paper
• In vivo cross-linking of nucleosomal histones catalyzed by nuclear transglutaminase in starfish sperm and its induction by egg jelly triggering the acrosome reaction.

  2003cites this paper
• Determination of the Subcellular Distribution of Mercaptoundecahydro-closo-dodecaborate (BSH) in Human Glioblastoma Multiforme by Electron Microscopy

  2002cites this paper
• Transglutaminase activity during senescence and programmed cell death in the corolla of tobacco (Nicotiana tabacum) flowers

  2002cites this paper
• Therapeutic Effects of Cystamine in a Murine Model of Huntington's Disease

  2002cites this paper
• Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases?

  2002cites this paper
• Identification of tissue transglutaminase‐reactive lysine residues in glyceraldehyde‐3‐phosphate dehydrogenase

  2002cites this paper
• CELLULAR AND SUBCELL CELLULAR AND SUBCELLULAR LOCALIZATION OF ULAR LOCALIZATION OF MERCAPTOUNDEC MERCAPTOUNDECAHYDRO-CLOSO-DODECABORATE (BSH) DODECABORATE (BSH) IN HUMAN GLIOBLASTOM IN HUMAN GLIOBLASTOMA MUL LTIFORME

  2001cites this paper
• N ε ‐(γ‐l‐Glutamyl)‐l‐lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease

  2001cites this paper
• N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease.

  2001cites this paper
• A sensitive fluorometric assay for tissue transglutaminase.

  2001cites this paper